CCR5 δ32 heterozygosity is associated with an increase in CXCR4 cell surface expression

AIDS Research and Human Retroviruses

Volumn 19, Issue 6, 2003, Pages 531-533

  Shalekoff, Sharon ^b   Tiemessen, Caroline T ^a  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; ALPHA CHEMOKINE; STROMAL CELL DERIVED FACTOR 1;

CELL SURFACE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; HETEROZYGOSITY; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; ADULT; GENE DELETION; GENETICS; HETEROZYGOTE; HUMAN; IMMUNOLOGY; LYMPHOCYTE SUBPOPULATION; METABOLISM; MIDDLE AGED; NATURAL KILLER CELL;

ADULT; CHEMOKINES, CXC; GENE DELETION; HETEROZYGOTE; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MIDDLE AGED; RECEPTORS, CCR5; RECEPTORS, CXCR4;

EID: 0038729194     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922203766774595     Document Type: Letter

References (19)

1. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, and Landau NR: Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996;381:661-666.
2. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-673.
3. Feng Y, Broder CC, Kennedy PE, and Berger EA: HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996;272:872-877.
4. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, and Berger EA: CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-1958.
5. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard C, and Sodroski J: The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:1135-1148.
6. + T cells. Science 1995;270:1811-1815.
7. Amara A, Gall SL, Schwartz O, Salamero J, Montes M, Loetscher P, Baggiolini M, Vimlizier JL, and Arenzana-Seisdedos F: HIV coreceptor downregulation as antiviral principle: SDF-1α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J Exp Med 1997;186:139-146.
8. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E, Donfield S, Vlahov D, Kaslow R, Saah A, Rinaldo C, Detels R, and O'Brien SJ: Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study [published erratum appears in Science 1996;274:1069]. Science 1996;273:1856-1862.
9. Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, He T, Kang S, Ceradini D, Jin Z, Yazdanbakhsh K, Kunstman K, Erickson D, Dragon E, Landau NR, Phair J, Ho DD, and Koup RA: The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996;2:1240-1243.
10. Samson M, Labbe O, Mollereau C, Vassart G, and Parmentier M: Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 1996;35:3362-3367.
11. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA, and Landau NR: Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996;86:367-377.
12. Zimmerman PA, Buckler-White A, Alkhatib G, Spalding T, Kubofcik J, Combadiere C, Weissman D, Cohen O, Rubbert A, Lam G, Vaccarezza M, Kennedy PE, Kumaraswami V, Giorgi JV, Detels R, Hunter J, Chopek M, Berger EA, Fauci AS, Nutman TB, and Murphy PM: Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: Studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol Med 1997;3:23-36.
13. Biolchini A, Curreli S, Ziccheddu M, Serra C, and Dolei A: Opposite effects of IFN-γ on CCR5 and CXCR4 expression and on entry of M- and T-tropic HIV in epithelial cells. AIDS 2000;14:613-615.
14. Shalekoff S and Tiemessen CT: Duration of sample storage dramatically alters expression of the human immunodeficiency virus coreceptors CXCR4 and CCR5. Clin Diagn Lab Immunol 2001;8:432-436.
15. Shalekoff S, Pendle S, Johnson D, Martin DJ, and Tiemessen CT: Distribution of the human immunodeficiency virus coreceptors CXCR4 and CCR5 on leukocytes of persons with human immunodeficiency virus type 1 infection and pulmonary tuberculosis: Implications for pathogenesis. J Clin Immunol 2001;21:390-401.
16. Wu L, Paxton WA, Kassam N, Ruffing N, Rottman JB, Sullivan N, Choe H, Sodroski J, Newman W, Koup RA, and Mackay CR: CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med 1997;185:1681-1691.
17. de Roda Husman AM, Blaak H, Brouwer M, and Schuitemaker H: CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection. J Immunol 1999;163:4597-4603.
18. Shalekoff S and Tiemessen CT: Circulating levels of stromal cell-derived factor IX and interleukin-7 in HIV type 1 infection and pulmonary tuberculosis are reciprocally related to CXCR4 expression on peripheral blood leukocytes. AIDS Res Human Retroviruses 2003;19:461-468.
19. Michael NL, Chang G, Louie LG, Mascola JR, Donero D, Birx DL, and Sheppard HW: The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nat Med 1997;3:338-340.